Skip to content
Screener

ClearPoint Neuro CLPT Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

IAR
Integra LifeSciencesIART
$13.92M-1.8%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$3.06M+0.4%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$2.26M+13.6%
Stryker logo
StrykerSYK
$161M0.0%
LivaNova logo
LivaNovaLIVN
$8.79M-6.3%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$11.23M+19.0%

Other financials

Income statement

See full
Revenue$12.1M+42.9%
Gross profit$7.8M+51.1%
Operating income-$8.5M-37.6%
Net income-$9.6M-58.5%
EPS (diluted)-$0.32-45.5%

Balance sheet

See full
Cash & equivalents$36.5M+195%
Total debt$63.6M+1,750%
Total equity$18.8M-5.7%
Total assets$93.4M+211%

Cash flow

See full
Operating cash flow-$8.0M-29.1%
CapEx$645.0K+252%
Free cash flow-$8.6M-35.5%

Valuation

See full
Market cap$444.45M+48.3%
Enterprise value$471.52M+60.7%
P/S10.9×+2.0×

Profitability

See full
Gross margin62.3%+1.1pp
Operating margin-65.2%-1.9pp
Net margin-71.6%+8.8pp
FCF margin-65.7%+269pp

Returns & leverage

See full
Return on equity-149.7%+4,074pp
Debt / equity3.4×+3.2×
Current ratio5.8×+2.3×

Where this comes from

Reported directly by ClearPoint Neuro in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The source filing: ClearPoint Neuro’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 5:00 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-221890
Line itemMarch 31, 2026 / (Unaudited)December 31, 2025
Accounts payable$2,330$1,256
Accrued compensation2,9774,360
Other accrued liabilities2,1252,786
Operating lease liabilities, current portion234694
Contract liabilities, current portion1,8141,669
Total current liabilities9,48010,765
Operating lease liabilities, net of current portion13,7108,461
Contract liabilities, net of current portion608581

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is ClearPoint Neuro's operating lease liabilities (current)?
ClearPoint Neuro (CLPT) reported operating lease liabilities (current) of $234K in Q1 2026.
How has ClearPoint Neuro's operating lease liabilities (current) changed year-over-year?
ClearPoint Neuro's operating lease liabilities (current) decreased by 59.5% year-over-year, from $578K to $234K.
What is the long-term trend for ClearPoint Neuro's operating lease liabilities (current)?
Over 5 years (2020 to 2025), ClearPoint Neuro's operating lease liabilities (current) has grown at a 12.0% compound annual growth rate (CAGR), from $394K to $694K.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Ask your AI about ClearPoint Neuro's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude